eFFECTOR Therapeutics Inc... (EFTR)
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -0.71 | -1.36 | 21.17 | 10.48 | -4.62 |
| PS Ratio | n/a | 4.96 | 233.87 | 3.55 | n/a |
| PB Ratio | -4.41 | 4.52 | 19.35 | -1.13 | -9.93 |
| P/FCF Ratio | -0.86 | -0.67 | -13.41 | 10.88 | -4.98 |
| P/OCF Ratio | -0.87 | -0.68 | -13.44 | 10.76 | -4.98 |
| OCF/S Ratio | n/a | -7.29 | -17.4 | 0.33 | n/a |
| Debt / Equity Ratio | -3.55 | 5.21 | 1.16 | -0.1 | -1.1 |
| Quick Ratio | 0.77 | 1.12 | 13.32 | 1.89 | 0.23 |
| Current Ratio | 0.77 | 1.12 | 13.30 | 1.89 | 0.23 |
| Asset Turnover | n/a | 0.12 | 0.03 | 2.51 | n/a |
| Interest Coverage | n/a | -14.39 | -18.08 | 11.87 | -20.71 |
| Return on Equity (ROE) | 6.18 | -3.32 | 0.91 | -0.11 | 2.15 |
| Return on Assets (ROA) | -1.74 | -0.44 | 0.29 | 0.85 | -5.84 |
| Return on Capital (ROIC) | 6.44 | -8.1 | -0.64 | 2.00 | 2.07 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | 98.51% | 98.32% | 48.02% | n/a |
| Net Profit Margin | n/a | -363.83% | 1.10K% | 33.84% | n/a |
| Pretax Profit Margin | n/a | -637.91% | 1.10K% | 34.67% | n/a |
| Operating Profit Margin | n/a | -911.99% | -2.23K% | 37.66% | n/a |
| FCF Margin | n/a | -734.34% | -1.74K% | 32.57% | n/a |
| EBITDA Margin | n/a | -911.99% | -2.23K% | 38.23% | n/a |